China NMPA published New DMF Requirement
On 16 July 2019, the China NMPA issued the Announcement on Further Improving the Binding Review, Approval and Supervision of Drugs (Announcement No. 56, 2019). This included updates to requirements for the filing and binding review of APIs, excipients, and pharmaceutical packaging materials. With this new announcement, Announcement No. 146, 2017 will be…